http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1317430-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
| filingDate | 2001-09-11^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-05-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d630df8e0978f99858e02c7a12f6d25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a45be64f5df5c7ea213ed35b0a4c15 |
| publicationDate | 2005-05-18^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1317430-B1 |
| titleOfInvention | (2-azabicyclo [2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists |
| abstract | The invention relates to substances of general formula (I), wherein X is selected from the following group: NH, NR4, O and S, R1 is selected from the following group: hydrogen, linear and branched, substituted and unsubstituted C¿1?-C10-alkyl groups, substituted and unsubstituted C5-C10-aryl groups, substituted and unsubstituted C4-C10-heteroaryl groups, acyl groups, thioacyl groups, carbonyl carboxy groups, N-organyl-substituted carbamoyl groups and organosulfonyl groups, R?2, R3¿, independently of each other, are chosen from the following group: C¿1?-C10-alkyl groups, C5-C12-aryl groups and C4-C12-heteroaryl groups, these groups being unsubstituted or having one or more substitutents which are chosen independently of each other from the following group: halogens, alkoxy groups, aryloxy groups, nitro groups, C1-C5-alkoxycarbonyl groups, alkyl or acyl groups and cyano groups, optionally substituted with fluorine, and R?4¿ is selected from the following group: hydrogen, linear and branched, substituted and unsubstituted C¿1?-C10-alkyl groups, substituted and unsubstituted C5-C10-aryl groups, substituted and unsubstituted C4-C10-heteroaryl groups, acyl groups, thioacyl groups, carbonyl carboxy groups, N-organyl-substituted carbamoyl groups and organosulfonyl groups; or a physiologically compatible salt thereof. |
| priorityDate | 2000-09-12^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 248 of 248.